Skip to main content
About Us
History
Our Leadership
Collaborations
Compliance & Ethics
Corporate Giving
Our Focus
Cerebral Adrenoleukodystrophy
Multiple Myeloma
Sickle Cell Disease
Transfusion Dependent Beta-Thalassemia
Our Science
What is Gene Therapy?
Gene Therapy Techniques
Our Pipeline
Clinical Trials
Our Products
Patients & Advocacy
Patient Advocacy
Patient Resources
Access Policy
Investors & Media
Contact Us
Careers
Stories
rewriting people's stories requires a different way of treating disease
let's recode your options
our products
ZYNTEGLO
®▼
(betibeglogene autotemcel)
Approved for patients in the European Union, UK, Iceland, Liechtenstein and Norway.
SmPC
